Pharma Product Quality Complaint
An encrypted pharmaceutical product quality complaint form. Covers product identification, defect type, patient impact, product availability for inspection and reporter details. Compliant with Swissmedic HMG, GDP guidelines and ICH Q10.
About this template
This template provides pharmaceutical manufacturers, marketing authorisation holders (MAHs), wholesalers, hospitals and community pharmacies with a structured product quality complaint form. It captures the minimum data required to investigate a quality defect in a medicinal product, including product identification, defect characterisation, patient impact assessment, sample availability and reporter details. All data is encrypted end-to-end.
What it collects
- Product name, lot number and expiry date for batch traceability
- Defect type classification (contamination, packaging, labelling, efficacy, appearance, other)
- Detailed description of the observed defect
- Patient impact — whether any harm or near-miss occurred
- Whether the defective product is available for physical inspection
- Source of the product (pharmacy, hospital, wholesaler)
- Reporter name, role and contact details
Swissmedic HMG and GDP reporting obligations
Quality defects in medicinal products must be investigated and — where they represent a potential risk to public health — reported to Swissmedic under HMG Article 15 (market withdrawal) and GDP guidelines. Marketing authorisation holders must maintain a written procedure for complaint handling and product recall, as required by ICH Q10 Pharmaceutical Quality System. This form supports the initial intake step of that procedure.
How to use it
Use this template
Click 'Use template' to create a copy in your dashboard.
Configure routing to your QA team
Route submissions directly to your Quality Assurance department inbox and set up the decryption key access for QA personnel only.
Assign a complaint number
On receipt of a submission, assign an internal complaint tracking number as required by your quality management system.
Assess and escalate
Assess risk classification (critical, major, minor) and trigger your recall, field safety correction or Swissmedic notification procedure as applicable.
Product quality complaint handling under ICH Q10 and GMP
ICH Q10, the international standard for pharmaceutical quality management systems, requires that manufacturers establish written procedures for receiving, evaluating, investigating, and closing product quality complaints. A quality complaint is any communication from outside the manufacturing site that concerns the quality of a distributed product. This includes complaints from healthcare professionals, patients, pharmacies, hospitals, wholesalers and regulatory bodies.
The complaint intake form is the first step in the complaint handling procedure. It must capture sufficient information to allow the QA team to: assess the severity and potential patient risk, determine whether the batch in question may still be in distribution, decide whether a market withdrawal or recall is necessary, initiate a root cause investigation, and file a Swissmedic notification if required.
Defect classification: critical, major, minor
Swissmedic and WHO guidelines classify product defects into three categories based on risk to public health:
- Critical defect: likely to cause a serious risk to health or death. Examples: microbial contamination of sterile products, wrong API, mislabelled product with wrong dose. Requires immediate action and Swissmedic notification.
- Major defect: may cause patient harm but is not immediately life-threatening. Examples: sub-potent product, tablet disintegration failure, incorrect package leaflet. Requires urgent investigation and probable recall.
- Minor defect: unlikely to cause harm but does not meet specification. Examples: cosmetic packaging defect, minor label error (batch number misprint). Requires investigation but may not require recall.
GDP requirements for complaint handling in the distribution chain
Good Distribution Practice (GDP) guidelines require wholesalers and distributors to maintain a written complaint procedure, investigate all complaints, and forward any complaints relating to product quality defects to the marketing authorisation holder. This form can be deployed at wholesale, hospital pharmacy or community pharmacy level to ensure complaints are captured systematically and forwarded to the MAH in a standardised format.
Frequently asked questions
When must a quality defect be reported to Swissmedic?
A quality defect must be reported to Swissmedic when it represents a potential risk to public health — specifically when it may affect the safety or efficacy of a distributed product. Critical defects must be reported immediately. Major defects generally require notification. Minor defects may be handled internally without mandatory reporting, but should be documented. Consult your QA team and regulatory affairs for classification.
What information does Swissmedic require for a recall notification?
Swissmedic requires: product name and form, lot number(s) affected, market distribution scope, nature of the defect, reason for recall, and proposed corrective and preventive actions. This form captures all the pre-investigation data. The full recall notification must be prepared by your QA and regulatory team using your validated recall procedure.
How should the defective product sample be handled?
The defective product sample should be quarantined, labelled as 'complaint sample — do not use' and stored under the appropriate storage conditions for that product. The sample should not be destroyed or returned to stock until the QA investigation is complete. If a physical inspection is to be conducted by the MAH, the reporter should be asked to retain the sample until collection or return instructions are provided.